MANE
Veradermics, Incorporated
NYSE · Healthcare · Biotechnology · US
$98.51
+0.78%Institutional positioning
13F filings over the trailing two quarters
New 179Increased 41Reduced 19Sold out 14
| Filer | Action | Shares | Filed |
|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | Unchanged | 4,168,970 | Aug 14, 2026 |
| SUVRETTA CAPITAL MANAGEMENT, LLC | New Position | 4,168,970 | May 15, 2026 |
| FMR LLC | Increased | 3,204,981 | Aug 13, 2026 |
| SR ONE CAPITAL MANAGEMENT, LP | New Position | 2,401,868 | May 14, 2026 |
| SR ONE CAPITAL MANAGEMENT, LP | Unchanged | 2,401,868 | Aug 12, 2026 |
| Deep Track Capital, LP | Increased | 2,000,000 | Aug 14, 2026 |
| CITADEL ADVISORS LLC | Increased | 1,877,775 | Sep 2, 2026 |
| CITADEL ADVISORS LLC | New Position | 1,825,672 | May 15, 2026 |
| FMR LLC | New Position | 1,792,909 | May 15, 2026 |
| VIKING GLOBAL INVESTORS LP | New Position | 1,690,555 | May 15, 2026 |
| Siren, L.L.C. | Increased | 1,655,374 | Aug 13, 2026 |
| BlackRock, Inc. | Increased | 1,593,791 | Aug 7, 2026 |
| VIKING GLOBAL INVESTORS LP | Reduced | 1,561,494 | Aug 14, 2026 |
| SIREN, L.L.C. | New Position | 1,505,374 | May 14, 2026 |
| JPMORGAN CHASE & CO | Increased | 1,165,584 | Aug 12, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings